About Beeline Medicines:
Beeline Medicines is a clinical‑stage biotechnology company focused on developing and delivering category-leading precision therapies to transform the lives of people living with autoimmune and inflammatory diseases. With a portfolio of potential best-in-class and first-in-disease therapeutic candidates that directly target key pathways governing dysregulated immunological and inflammatory responses, the Company is developing medicines that have the opportunity to provide durable, life-changing impact. Led by an established executive team and backed by world-class life science investors, each day Beeline Medicines is determined to bring the scientific rigor and operational excellence to get to what matters for patients – realizing a world where people with immune-mediated diseases can live life fully.
Job Summary:
The Senior Clinical Trial Manager (Sr. CTM) will lead the operational planning, execution, and oversight of complex, global clinical studies in the field of immunology and autoimmune diseases. This role is responsible for ensuring studies are delivered on time, within scope, and in compliance with regulatory standards, Good Clinical Practice (GCP), and company Standard Operating Procedures (SOPs). The Sr. CTM will partner closely with internal cross-functional teams (Clinical Development, Regulatory, Biometrics, Safety, and Quality) and external partners (CROs, vendors, and sites) to ensure operational excellence. This individual will also play a critical role in driving strategic decision-making and supporting inspection readiness and regulatory submissions.
Work Arrangement & Location:
Remote - This position is designated as remote; the incumbent will be expected to travel to Beeline Medicines’ offices on a periodic basis to support in-person collaboration, team engagement, and business operations. The frequency and scheduling of such visits will be determined at the company's discretion based on business need.
Essential Duties and Responsibilities:
- Lead the operational strategy, planning, and execution of global Phase 1–4 clinical trials in immunology indications (e.g., autoimmune and inflammatory diseases).
- Serve as the primary operational point of contact for internal stakeholders and external partners.
- Oversee the selection and management of CROs and other vendors, including scope of work, budget development, contracting, and performance oversight.
- Drive site feasibility, site selection, activation, patient recruitment strategies, and ongoing site management to ensure achievement of enrollment goals.
- Develop and maintain study timelines, risk mitigation strategies, and operational tracking tools.
- Collaborate with cross-functional teams on protocol development, CRF design, ICF review, and development of operational study plans.
- Ensure studies are conducted in compliance with GCP/ICH guidelines, local regulatory requirements, and internal SOPs.
- Proactively identify and resolve operational issues, escalating risks and implementing mitigation strategies as needed.
- Oversee data collection activities, database lock readiness, and support data review processes.
- Contribute to regulatory filings, inspection readiness, and audit preparation.
- Provide leadership and mentorship to Clinical Operations team members.
- Contribute to process improvement initiatives within Clinical Operations to enhance efficiency and quality.
- Perform other duties and responsibilities as assigned
Qualifications:
- Education: Bachelor’s degree in life sciences or related field (advanced degree preferred)
- Minimum 5 years of experience in clinical operations in the biopharmaceutical industry, with at least 3 years in a Senior CTM or equivalent leadership role.
- Proven track record of managing global, multi-center clinical trials in immunology or autoimmune disease indications.
- Experience with biologics, monoclonal antibodies, or advanced therapies.
- Strong knowledge of GCP/ICH guidelines, clinical trial regulations, and operational best practices.
- Experience in rare autoimmune indications or immune-mediated inflammatory diseases.
- Familiarity with adaptive trial designs or complex biomarker-driven studies.
- Experience in early- to late-stage development programs, including pivotal trials.
- Proficiency with electronic systems such as CTMS, EDC, eTMF, and risk-based monitoring tools.
- Ability to thrive in a fast-paced, dynamic environment and work independently with minimal supervision
- Excellent communication, leadership, and problem-solving skills.
- This position requires availability during Eastern Time (ET) business hours
- This role may require domestic and international travel, including overnight stays, up to 20% or more based on business needs
Salary Range:
The expected salary range for this position varies by location and will be communicated based on the country or region in which the selected candidate is hired. Actual pay will be determined based on experience, qualifications, location, and other job-related factors permitted by applicable local law. A discretionary annual bonus and long-term incentive award (e.g., equity) may be available based on individual and Company performance.
Benefits:
We offer a comprehensive benefits package tailored to the country and region in which you are hired, in compliance with local laws and practices. Benefits may include, but are not limited to:
- Competitive health and wellness coverage (structure and premiums vary by country)
- Paid time off, public holidays, and additional leave entitlements in accordance with local requirements
- Flexible work arrangements / hybrid schedule
Benefits vary by location and are subject to eligibility requirements, local regulations, and plan terms. Specific benefit details applicable to your country or region will be provided during the offer process.
Equal Employment Opportunity:
Beeline Medicines is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity or expression, national origin, disability, age, protected veteran status, or any other characteristic protected by applicable federal, state, or local law.
Reasonable Accommodation:
If you require a reasonable accommodation to participate in the application or interview process, please contact [email protected] to request an accommodation. We are committed to providing equal access to all candidates.
Privacy
Upon submission of this form I understand that Beeline Medicines is based in the United States and personal data submitted in the form will be transferred and accessed in the U.S., Information about Beeline Medicines privacy practices can be found at Privacy Policy - Beeline Medicines
Skills Required
- Bachelor's degree in life sciences or related field
- Advanced degree (MS/PhD) in relevant field
- Minimum 5 years clinical operations experience in biopharmaceutical industry
- At least 3 years in a Senior CTM or equivalent leadership role
- Proven track record managing global, multi-center clinical trials in immunology/autoimmune indications
- Experience with biologics, monoclonal antibodies, or advanced therapies
- Strong knowledge of GCP/ICH guidelines and clinical trial regulations
- Experience in rare autoimmune indications or immune-mediated inflammatory diseases
- Familiarity with adaptive trial designs or complex biomarker-driven studies
- Experience across early- to late-stage development programs, including pivotal trials
- Proficiency with electronic systems such as CTMS, EDC, eTMF, and risk-based monitoring tools
- Excellent communication, leadership, and problem-solving skills
- Availability during Eastern Time (ET) business hours
- Willingness to travel domestically and internationally, including overnight stays, up to ~20% or more
What We Do
Beeline Medicines is a clinical-stage biotechnology company focused on developing and delivering category-leading precision therapies for people living with autoimmune and inflammatory diseases. The company leverages a mechanistically-guided approach to target the underlying drivers of immune dysfunction, aiming to define new treatment paradigms and provide durable, life-changing impact for patients suffering from a broad array of devastating immune-mediated conditions to improve patient outcomes.
